Absolutely.
Diabetes generally—and type 1 diabetes—has benefited incredibly over the last few years from advances in technologies, some of which you've heard about today from the kids providing their testimony, with both insulin pumps and continuous glucose monitoring. The JDRF Canadian Clinical Trial Network is helping take those technologies a step further.
Our goal here today is to try to garner your support in expanding that trial network across Canada to give access to those technologies to all Canadians, because that is a mechanism that's providing Canadians with the opportunity to see those technologies earlier than others in the world today. In fact, we're a couple of years ahead with the technology that's available here in Canada relative to the United States at the moment. We want to help develop the knowledge economy around...and expand on our history of excellence in diabetes research.
That is a position that Canada holds, and holds very well. We're well regarded in the world. That's our goal here today, to try to expand that human clinical trial network, because that is what's taking those breakthroughs in laboratories and in industry and delivering them to the market.